Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 53056 · Class II · Continental Services Group, Inc.
Key facts
| Event ID | 53056 |
|---|---|
| Recall numbers | B-1203-13 |
| Recalling firm | Continental Services Group, Inc. |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, which was labeled as negative for hepatitis B surface antigen (HBsAg), but tested positive for HBsAg, was distributed. |
| Initiation date | Feb 26, 2009 |
| Report date | Mar 20, 2013 |
| Termination date | Mar 11, 2013 |
| City | Miami |
| State | FL |
| Country | United States |
| FEI number | 1070217 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: